|Daily Range||$227.50 - $251.00|
|52-Week Range||$30.38 - $497.00|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||718,960|
|Current FY EPS||-$3.32|
Intercept Pharmaceuticals, Inc. (ICPT) Description
Intercept Pharmaceuticals, Inc. Website: http://www.interceptpharma.com/
Biotech dominates in January as Intercept, Cell Therapeutics, and Neurocrine all surge after good drug-trial news.
Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., Micron Technology Inc., Facebook Inc.
Sector Update: Healthcares Flat to Lower Pre-Market; Lexicon Soars 20% on Study of Diabetes Treatment
Intercept Issues Preclinical Data Showing OCA's Potential Role in Preventing Complications of Cirrhosis